3 results match your criteria: "and Inflammation-Immunopathology-Biotherapy Department (DHU i2B) Sorbonne Universités Paris France.[Affiliation]"

Article Synopsis
  • Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) show potential as a cell-free therapy for lung injuries, particularly through nebulization of human adipose-derived MSC-EVs (haMSC-EVs).
  • In a preclinical study, nebulization improved survival rates in a murine lung injury model, reducing inflammation and histological damage.
  • Safety trials with 24 healthy volunteers indicated that haMSC-EVs were well-tolerated, with no serious adverse effects reported, supporting their future clinical use for lung injury treatments.
View Article and Find Full Text PDF

Background Data regarding long-term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long-term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. Methods and Results Retrospective multicenter study of characteristics and outcomes of 224 thromboangiitis obliterans patients fulfilling Papa's criteria were analyzed.

View Article and Find Full Text PDF

In this case study, we report the longitudinal and multimodal follow-up of a catastrophic initial presentation of cerebral fat embolism syndrome. We show that despite the initial severity, the cognitive outcome was ultimately very good but with a highly nonlinear time-course and prolonged loss of consciousness (more than 2 months). Repeated clinical assessments and brain-imaging techniques (electroencephalography, event-related potential, -Fluoro-Deoxy-Glucose-PET and magnetic resonance imaging) allowed us to monitor and anticipate this dynamic, providing relevant information to guide decision making in front of withdrawal of life-sustaining therapy discussions.

View Article and Find Full Text PDF